TrialWiener klinische Wochenschrift2009

Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.

Ligia Petrica et al.PubMed ↗Publisher ↗

No numbers read from the abstract.